MOONLAKE IMMUNOTHERAPEUTICS Class A Ordinary Shares (par value $0.0001 per share) SALES AGREEMENTSales Agreement • May 11th, 2023 • MoonLake Immunotherapeutics • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2023 Company Industry JurisdictionMoonLake Immunotherapeutics, a Cayman Islands exempted company (the “Company”), confirms its agreement (this “Agreement”) with SVB Securities LLC (the “Agent”), as follows: